Where broad venture capital, operational and governance experience come together to catalyze, transform and invest in existing and future Life Science companies.
Employees: 1-10
Investment Type: Venture Capital
Portfolio 3
| Date | Name | Website | Total Raised | Location |
| 09.01.2023 | Amolyt Pha... | amolytpharma.com | $218M | France, Au... |
| 04.06.2021 | VectivBio ... | vectivbio.com | $324M | Switzerlan... |
| - | Find Thera... | findtherapeutics.com | - | Canada, Qu... |
News 61
Show more
Mentions in press and media 21
| Date | Title | Description |
| 11.03.2024 | AbilityPharma cierra una ronda de €7M liderada por CTI Life Sciences Fund, Inveready y EIC Fund. Participan CDTI Innvierte, FiTalent, fundadores y CapitalCell | 11/03/2024 Nota de prensa ABILITYPHARMA CIERRA UNA RONDA DE €7M PARA EL FÁRMACO ABTL0812 EN FASE CLÍNICA 2B EN CÁNCER DE PÁNCREAS METASTÁTICO El fondo de capital riesgo (venture capital) canadiense CTI Life Sciences Fund, Inveready y el EIC... |
| 12.01.2023 | French pharma Amolyt nets €130 million series C co-led by Sofinnova Partners | Amolyt Pharma, an Ecully, France-based pharma startup working on rare disease treatments, has closed a €130 million series C round. Amolyt is targeting rare indications affecting the body's hormone supply from endocrine glands. The series C... |
| 25.04.2022 | Advancing cancer treatments, medtech startup Epitopea raises £10.3 million | Cambridge-based Epitopea has raised £10.3 million in a seed funding round. The medtech startup is developing off-the-shelf cancer immunotherapies designed to treat a broad patient population. The influx of capital will be used to further ad... |
| 10.05.2021 | CTI Life Sciences Fund raises $100 million in first close of third venture fund | Montréal-based venture capital firm CTI Life Sciences Fund has raised $100 million CAD in the first close of its third venture fund. The fund’s limited partners include previous investors such as Fonds de solidarité FTQ, Caisse de dépôt et ... |
| 10.05.2021 | CTI Life Sciences Fund Successfully Raises $100 Million As A First Tranche of its Third Venture Capital Fund | - |
| 10.05.2021 | CTI Life Sciences Fund secures initial C$100m for third pool | - |
| 09.07.2020 | THE BLACKSTONE GROUP INC. Blackstone : Announces $4.6 Billion Final Close of Life Sciences Fund | Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences V (“BXLS V”), the inaugural Blackstone fund in Life Sciences. BXLS V was oversubscribed and closed at its hard cap of $4.6 billion of total capital commitment... |
| 08.06.2020 | Find Therapeutics, a new drug development company dedicated to breakthrough therapies against rare diseases launches in Montreal | The new company raises initial capital to develop transmembrane peptides against GPCRs to address high unmet needs. Montreal, Canada – June 8, 2020: CTI Life Sciences, along with partners adMare BioInnovations, Domain Therapeutics and Pepti... |
| 06.05.2016 | Amgen Backs New $315M Life Sciences Fund | Thousand Oaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-based venBio, as an anchor supporter of a new fund. venBio said Friday that it has closed a $315M life sciences fund, venBio Global Strategic F... |
| 10.07.2015 | Xagenic Raises CAD$15M in Funding | Xagenic, a Toronto, Canada-based molecular diagnostics company developing the lab-free Xagenic X1™ platform for use at the point of care, raised CAD$15M in funding. Backers included Domain Associates, CTI Life Sciences, BDC Capital and the ... |
Show more